These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 20696094)

  • 1. Metabolic and hormonal aspects of polycystic ovary syndrome: the impact of diet.
    O'Connor A; Gibney J; Roche HM
    Proc Nutr Soc; 2010 Nov; 69(4):628-35. PubMed ID: 20696094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary therapy in polycystic ovary syndrome.
    Moran LJ; Brinkworth GD; Norman RJ
    Semin Reprod Med; 2008 Jan; 26(1):85-92. PubMed ID: 18181086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin resistance is not strictly associated with energy intake or dietary macronutrient composition in women with polycystic ovary syndrome.
    Toscani MK; Mario FM; Radavelli-Bagatini S; Spritzer PM
    Nutr Res; 2011 Feb; 31(2):97-103. PubMed ID: 21419313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding and managing disturbances in insulin metabolism and body weight in women with polycystic ovary syndrome.
    Moran L; Norman RJ
    Best Pract Res Clin Obstet Gynaecol; 2004 Oct; 18(5):719-36. PubMed ID: 15380143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular risk in women with polycystic ovary syndrome.
    Giallauria F; Orio F; Palomba S; Lombardi G; Colao A; Vigorito C
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):987-92. PubMed ID: 18799960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
    Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G
    Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of obesity on reproduction in women with polycystic ovary syndrome.
    Pasquali R; Gambineri A; Pagotto U
    BJOG; 2006 Oct; 113(10):1148-59. PubMed ID: 16827825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial of the effects of two types of short-term hypocaloric diets on weight loss in women with polycystic ovary syndrome.
    Stamets K; Taylor DS; Kunselman A; Demers LM; Pelkman CL; Legro RS
    Fertil Steril; 2004 Mar; 81(3):630-7. PubMed ID: 15037413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diet and nutrition in polycystic ovary syndrome (PCOS): pointers for nutritional management.
    Farshchi H; Rane A; Love A; Kennedy RL
    J Obstet Gynaecol; 2007 Nov; 27(8):762-73. PubMed ID: 18097891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgens in polycystic ovary syndrome: the role of exercise and diet.
    Giallauria F; Palomba S; Vigorito C; Tafuri MG; Colao A; Lombardi G; Orio F
    Semin Reprod Med; 2009 Jul; 27(4):306-15. PubMed ID: 19530064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity and the polycystic ovary syndrome.
    Martínez-Bermejo E; Luque-Ramírez M; Escobar-Morreale HF
    Minerva Endocrinol; 2007 Sep; 32(3):129-40. PubMed ID: 17912153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of obesity and adiposity in polycystic ovary syndrome.
    Diamanti-Kandarakis E
    Int J Obes (Lond); 2007 Nov; 31 Suppl 2():S8-13; discussion S31-2. PubMed ID: 17968437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of lifestyle modification in the management of polycystic ovary syndrome.
    Hoeger KM
    Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):293-310. PubMed ID: 16772159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipose tissue dysfunction, adipokines, and low-grade chronic inflammation in polycystic ovary syndrome.
    Spritzer PM; Lecke SB; Satler F; Morsch DM
    Reproduction; 2015 May; 149(5):R219-27. PubMed ID: 25628442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Dietary Medium-Chain Fatty Acid, Decanoic Acid, Inhibits Recruitment of Nur77 to the HSD3B2 Promoter In Vitro and Reverses Endocrine and Metabolic Abnormalities in a Rat Model of Polycystic Ovary Syndrome.
    Lee BH; Indran IR; Tan HM; Li Y; Zhang Z; Li J; Yong EL
    Endocrinology; 2016 Jan; 157(1):382-94. PubMed ID: 26465200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary composition in the treatment of polycystic ovary syndrome: a systematic review to inform evidence-based guidelines.
    Moran LJ; Ko H; Misso M; Marsh K; Noakes M; Talbot M; Frearson M; Thondan M; Stepto N; Teede HJ
    J Acad Nutr Diet; 2013 Apr; 113(4):520-45. PubMed ID: 23420000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focus on metabolic and nutritional correlates of polycystic ovary syndrome and update on nutritional management of these critical phenomena.
    Rondanelli M; Perna S; Faliva M; Monteferrario F; Repaci E; Allieri F
    Arch Gynecol Obstet; 2014 Dec; 290(6):1079-92. PubMed ID: 25200687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity and polycystic ovary syndrome.
    Barber TM; McCarthy MI; Wass JA; Franks S
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):137-45. PubMed ID: 16886951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
    Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
    Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study.
    Florakis D; Diamanti-Kandarakis E; Katsikis I; Nassis GP; Karkanaki A; Georgopoulos N; Panidis D
    Int J Obes (Lond); 2008 Apr; 32(4):692-9. PubMed ID: 18071341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.